Grace Therapeutics logo

Grace Therapeutics Share Price (NASDAQ: GRCE)

$3.03

0.04

(1.34%)

Last updated on

Check the interactive Grace Therapeutics Stock chart to analyse performance

Grace Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.92
    Today's High:$3.05

    Day's Volatility :4.11%

  • 52 Weeks Low:$1.75
    52 Weeks High:$4.97

    52 Weeks Volatility :64.75%

Grace Therapeutics Stock Returns

PeriodGrace Therapeutics IncIndex (Russel 2000)
3 Months
8.36%
0.0%
6 Months
14.91%
0.0%
1 Year
19.18%
0.0%
3 Years
-37.35%
-4.1%

Grace Therapeutics Inc Key Stats

Check Grace Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.99
Open
$2.97
Today's High
$3.045
Today's Low
$2.92
Market Capitalization
$35.0M
Today's Volume
$62.1K
52 Week High
$4.965
52 Week Low
$1.75
Revenue TTM
$0.0
EBITDA
$-16.7M
Earnings Per Share (EPS)
$-1.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-22.89%

Stock Returns calculator for Grace Therapeutics Stock including INR - Dollar returns

The Grace Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Grace Therapeutics investment value today

Current value as on today

₹1,23,643

Returns

₹23,643

(+23.64%)

Returns from Grace Therapeutics Stock

₹18,359 (+18.36%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Grace Therapeutics Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Grace Therapeutics Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Grace Therapeutics Stock

Rating
Trend

Grace Therapeutics Share Price Target

What analysts predicted

Upside of 284.48%

Target:

$11.65

Current:

$3.03

Grace Therapeutics share price target is $11.65, a slight Upside of 284.48% compared to current price of $3.03 as per analysts' prediction.

Grace Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, GRCE stock has moved down by -6.3%
  • GRCE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 53.7%
  • GRCE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 153.6%

Grace Therapeutics Technicals Summary

Sell

Neutral

Buy

Grace Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Grace Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Grace Therapeutics Inc logo
5.36%
14.91%
19.18%
-37.35%
-71.15%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Grace Therapeutics Inc

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Organization
Grace Therapeutics
Employees
6
CEO
Mr. Prashant Kohli
Industry
Miscellaneous

Key Management of Grace Therapeutics Inc

NameTitle
Mr. Prashant Kohli
CEO & Director
Mr. Amresh Kumar Ph.D.
VP of Program Management
Ms. Carrie D'Andrea
VP of Clinical Operations
Mr. Robert J. DelAversano CPA
VP of Finance and Principal Financial & Accounting Officer
Dr. R. Loch MacDonald M.D., Ph.D.
Member of Scientific Advisory Board & Chief Medical Officer

Important FAQs about investing in GRCE Stock from India :

What is Grace Therapeutics share price today?

Grace Therapeutics share price today is $3.03 as on at the close of the market. Grace Therapeutics share today touched a day high of $3.05 and a low of $2.92.

What is the 52 week high and 52 week low for Grace Therapeutics share?

Grace Therapeutics share touched a 52 week high of $4.97 and a 52 week low of $1.75. Grace Therapeutics stock price today i.e. is closed at $3.03, lower by 38.97% versus the 52 week high.

How to invest in Grace Therapeutics Stock (GRCE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Grace Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Grace Therapeutics Shares that will get you 0.4950 shares as per Grace Therapeutics share price of $3.03 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Grace Therapeutics Stock (GRCE) from India?

Indian investors can start investing in Grace Therapeutics (GRCE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Grace Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Grace Therapeutics share’s latest price of $3.03 as on August 30, 2025 at 1:29 am IST, you will get 3.3003 shares of Grace Therapeutics. Learn more about fractional shares .

What are the returns that Grace Therapeutics has given to Indian investors in the last 5 years?

Grace Therapeutics stock has given -71.15% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?